Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system have?
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system has 581 citations in the OpenAlex counts ScholarIQ stores.
When was Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system published?
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system has 2004 year in the ScholarIQ index.
What is the open-access status of Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system?
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system has closed oa status in the ScholarIQ index.
What is the DOI of Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system?
The DOI for Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system is on the source record.
What is the PMID of Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system?
The PMID for Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system is on the source record.
What is the OpenAlex record for Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system?
The OpenAlex for Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system is on the source record.